skip to main content

ProfessionalsJonathan H. Ashtor

Jonathan H. Ashtor

Tel: +1-212-373-3823
Fax: +1-212-492-0823

Tel: +1-212-373-3823
New York

1285 Avenue of the Americas
New York, NY 10019-6064
Fax: +1-212-492-0823

Bar Admissions 
Bar Admissions 

Jonathan Ashtor is Global Co-Head of Intellectual Property & Technology Transactions and a partner in the Corporate Department. His practice focuses on technology M&A transactions, IP licensing, technology development and collaboration agreements, AI services and hosting agreements and technology dispute resolution and advisory work. His experience has included major, complex and multi-jurisdictional M&A, including public company mergers, private equity and venture-backed transactions, spinoffs and joint ventures. He advises clients across a variety of industry sectors, including computer & semiconductor technologies, life sciences & biotech, emerging technologies, e-commerce & media, industrial chemicals and manufacturing, among others.

Awards & Recognitions

In 2023, Jonathan was recognized by Bloomberg Law in its “They’ve Got Next: 40 Under 40” and one of the “500 Leading Dealmakers in America” by Lawdragon. Jonathan was ranked among the Top 10 Intellectual Property Lawyers in North America in 2021 by MergerLinks. In 2015, Jonathan was ranked by the Financial Times North America as an “Innovative Lawyer”.


Some recent transactions include:


  • HP in its $1.05 billion acquisition of the global printer business of Samsung Electronics, including negotiating ancillary intellectual property-related agreements and structuring certain aspects of the separation of the business
  • IBM in its:
    • pending $6.4 billion acquisition of HashiCorp
    • sale of The Weather Company to Francisco Partners
    • $4.6 billion acquisition of Apptio
    • acquisition of NS1, Neudesic and Envizi
    • $34 billion acquisition of Red Hat, creating the world’s largest hybrid cloud provider
    • spin-off of the market-leading managed infrastructure services business into a new public company, Kyndryl Holdings
  • Magnachip Semiconductor Corporation in its:
    • $1.4 billion take-private sale to investment vehicles established by Wise Road Capital and certain of its limited partners
    • sale, valued at approximately $435 million, of its Foundry Services Group and fabrication plant in Cheongju, Korea by certain of MagnaChip’s wholly-owned subsidiaries to a special purpose company established by Alchemist Capital Partners Korea, and Credian Partners
  • Mitel Networks in its $530 million acquisition of ShoreTel, involving the acquisition of a significant international IP portfolio, as well as advising on IP issues relating to outbound affiliate licenses and historical IP disputes; and in Mitel’s approximately $2 billion acquisition by an investor group led by affiliates of Searchlight Capital Partners
  • Special Committee of QAD in its $2 billion sale to private equity firm Thomas Bravo
  • Qualcomm in its proposed acquisition of NXP Semiconductors N.V. for approximately $47 billion
  • Representation of certain private equity and hedge fund clients in connection with technology M&A and licensing transactions, including IT and data rights arrangements


  • AbbVie in its up to $212.5 million acquisition of Landos Biopharma
  • Albireo in:
    • its sale to Ipsen
    • a $115 million royalty monetization agreement with Sagard Healthcare Partners
  • Alexion Pharmaceuticals in its $1.4 billion acquisition of Portola Pharmaceuticals
  • Amazon in its $3.9 billion acquisition of One Medical
  • Catalent in the sale of its Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing Business to funds advised by SK Capital Partners
  • Elanco Animal Health in its $7.6 billion carve-out acquisition of the animal health business of Bayer AG and subsequent secondary offering of common stock
  • General Electric in the $21.4 billion sale of its BioPharma business to Danaher Corporation
  • GSK in its $2 billion acquisition of BELLUS Health
  • Inhibrx in the $2.2 billion sale of INBRX-101 to Sanofi and the related spin-off of Inhibrx's non-101 assets and liabilities, non-101 discovery pipeline and its corporate infrastructure, to create a new publicly traded company known as Inhibrx Biosciences
  • The Medicines Company in its $9.7 billion sale to Novartis AG
  • Merck in its $10.8 billion acquisition of Prometheus Biosciences
  • PRA Health Sciences in its acquisition of ICON for approximately $12 billion
  • Teladoc Health in its $18.5 billion acquisition of Livongo Health


  • A leading pharmaceutical company in connection with implementing a wide range of generative AI use cases across their organization, including leading negotiations with significant AI hosting and services vendors, risk assessment, analysis of regulatory developments and coordination with business leads and digital technology stakeholders
  • Aptiv in its:
    • $4.3 billion acquisition of Wind River from TPG Capital
    • $4 billion autonomous driving joint venture with Hyundai Motor Group
  • FIFA in its sponsorship deal and technical partnership with blockchain technology innovator Algorand, including the creation of an NFT platform
  • Nuance Communications in its:
    • $19.7 billion sale to Microsoft
    • spin-off of its automotive software business
    • $400 million sale of its Document Imaging division to Kofax
  • Qualcomm in its $4.5 billion topping bid for Veoneer. As part of the transaction, Veoneer terminated its prior agreement with Magna International
  • Numerous clients on AI-related matters, including Apollo Global Management and Bridgewater Associates 


  • Adjust in its sale to AppLovin
  • Advance in its acquisition of Palladian Holdings, owner of Turnitin, from an investment entity affiliated with Insight Venture Partners, GIC and their co-investors
  • Endeavor Streaming in connection with the negotiation and drafting of key technology services agreements with WWE for the operation and support of its WWE Network streaming platform
  • Ericsson in the divestment of a 51% ownership stake in its Media Solutions business to One Equity Partners. The Media Solutions business offers a wide-ranging media portfolio, including hardware and software video compression solutions, and serves a broad base of operators, service providers, broadcasters, content providers and aggregators. The transaction structure is intended to further develop the Media Solutions business and establish it as a leading independent video technology company. The transaction involved advising on several technology licensing matters
  • Farelogix in its sale to Accelya
  • Golden Gate Capital in its:
    • acquisition of Securly, from the company’s shareholders
    • sale of a majority stake of its portfolio company Vector Solutions to Genstar Capital
    • $3.1 billion sale of Neustar to TransUnion
  • TeraWulf in its $200 million in debt and equity financing consisting of a secured term loan and subscriptions agreements with investors to purchase newly issued shares of common stock, and in becoming a Nasdaq-listed public company through a business combination with IKONICS Corporation


  • Funds managed by affiliates of Berkshire Partners in their acquisition of FoodChain ID from Paine Schwartz Partners
  • Brooks Automation in the separation of its business into two independent, publicly-traded companies
  • General Atlantic in various technology-focused acquisitions and investments across multiple industries including business services, financial services, healthcare, internet, and retail and consumer products, including alongside other investors, in the
    $105 million investment in Talos
  • General Electric in its:
    • separation into three distinct companies focusing on health care, energy and aviation: GE Healthcare, GE Vernova and GE Aerospace
    • combination of its jet leasing unit, GE Capital Aviation Services (GECAS), with Dublin-based AerCap Holdings NV in a cash-and-stock transaction valued at more than $30 billion
  • Honeywell in its spin-off of Garrett Motion, Honeywell’s former Transportation Systems business
  • Mitsubishi Chemical America in its acquisition of Gelest from New Mountain Capital
  • SoftBank Vision Fund, alongside various global investors, in the $1.9 billion investment in Full Truck Alliance
  • Trane Technologies in the $15 billion Reverse Morris Trust spinoff and merger of its industrial business with Gardner Denver Holdings, creating a $15 billion global leader in mission-critical flow and industrial technologies
  • Virtu Financial in its:
    • approximately $1 billion acquisition of Investment Technology Group
    • approximately $1.4 billion acquisition of KCG Holdings and in the related
      $750 million investment in Virtu by North Island, GIC, Public Sector Pension Investment Board and Temasek

Jonathan’s expertise includes complex analytics of patent matters through the use of proprietary models and commercial databases, and he develops new analytics tools through his academic research appointments. He has published numerous thought leadership pieces and empirical studies focused on patents and innovation economics, and he regularly presents at research and practitioner conferences worldwide.

Jonathan is also a Professor of Practice at the Benjamin N. Cardozo School of Law, where he designed and teaches a course on Technology Transactions.

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy